Suchergebnisse - "Modi, Dimple"

PubPharm (30)

1

In situ evaluation of the impact of metformin or verapamil coadministration with vildagliptin on its regional absorption from the rabbit's intestine

enthalten in: Biopharmaceutics & drug disposition | 2024

von Elmeniar, A. | Osman, M. | El-Gizawy, S. | +6

2

Current Progress and Emerging Role of Essential Oils in Drug Delivery Therapeutics

enthalten in: Current drug delivery | 2024

von Sultana, R. | Mohanto, S. | Bhunia, A. | +7

3

Enhancing Oil Solubility of BCS Class II Drug Phenytoin Through Hydrophobic Ion Pairing to Enable High Drug Load in Injectable Nanoemulsion to Prevent Precipitation at Physiological pH With a Potential to Prevent Phlebitis

enthalten in: Journal of pharmaceutical sciences | 2023

von Modi, D. | Jonnalagadda, S. | Campbell, G. | +1

4

Activity of eftozanermin alfa plus venetoclax in preclinical models and patients with acute myeloid leukemia

enthalten in: Blood | 2023

von Tahir, S. | Calvo, E. | Carneiro, B. | +17

5

Eftozanermin alfa (ABBV-621) monotherapy in patients with previously treated solid tumors : findings of a phase 1, first-in-human study

enthalten in: Investigational new drugs | 2022

von LoRusso, P. | Ratain, M. | Doi, T. | +14

6

Co-clinical Modeling of the Activity of the BET Inhibitor Mivebresib (ABBV-075) in AML

enthalten in: In vivo (Athens, Greece) | 2022

von Albert, D. | Goodwin, N. | Davies, A. | +21

7

Eftozanermin alfa (ABBV-621) monotherapy in patients with previously treated solid tumors: findings of a phase 1, first-in-human study

enthalten in: Investigational new drugs | 2022

von LoRusso, P. | Ratain, M. | Doi, T. | +14

8

Eftozanermin alfa (ABBV-621) monotherapy in patients with previously treated solid tumors: findings of a phase 1, first-in-human study

enthalten in: Investigational new drugs | 2022

von LoRusso, P. | Ratain, M. | Doi, T. | +14

9

Eftozanermin alfa (ABBV-621) monotherapy in patients with previously treated solid tumors: findings of a phase 1, first-in-human study

enthalten in: Investigational new drugs | 2022

von LoRusso, P. | Ratain, M. | Doi, T. | +14

10

A phase 1 study of the pan-bromodomain and extraterminal inhibitor mivebresib (ABBV-075) alone or in combination with venetoclax in patients with relapsed/refractory acute myeloid leukemia

enthalten in: Cancer | 2021

von Borthakur, G. | Odenike, O. | Aldoss, I. | +8